Cas no 263277-12-9 (Benzyl 4-(benzyloxy)-3-hydroxybenzoate)
Benzyl 4-(benzyloxy)-3-hydroxybenzoate Chemical and Physical Properties
Names and Identifiers
-
- Benzyl 4-(benzyloxy)-3-hydroxybenzoate
- benzyl 3-hydroxy-4-phenylmethoxybenzoate
- SCHEMBL3960881
- VJEWLMHAPKBHFM-UHFFFAOYSA-N
- 263277-12-9
- benzyl 4-benzyloxy-3-hydroxy-benzoate
- benzyl 4-benzyloxy-3-hydroxybenzoate
- Benzyl4-(benzyloxy)-3-hydroxybenzoate
- Benzoic acid, 3-hydroxy-4-(phenylmethoxy)-, phenylmethyl ester
-
- Inchi: 1S/C21H18O4/c22-19-13-18(21(23)25-15-17-9-5-2-6-10-17)11-12-20(19)24-14-16-7-3-1-4-8-16/h1-13,22H,14-15H2
- InChI Key: VJEWLMHAPKBHFM-UHFFFAOYSA-N
- SMILES: O(CC1C=CC=CC=1)C1C=CC(C(=O)OCC2C=CC=CC=2)=CC=1O
Computed Properties
- Exact Mass: 334.12050905g/mol
- Monoisotopic Mass: 334.12050905g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 25
- Rotatable Bond Count: 7
- Complexity: 399
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 4.4
- Topological Polar Surface Area: 55.8?2
Benzyl 4-(benzyloxy)-3-hydroxybenzoate Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019093347-1g |
Benzyl 4-(benzyloxy)-3-hydroxybenzoate |
263277-12-9 | 95% | 1g |
$400.00 | 2023-09-02 | |
| Cooke Chemical | BD8527447-1g |
Benzyl4-(benzyloxy)-3-hydroxybenzoate |
263277-12-9 | 95+% | 1g |
RMB 1208.80 | 2025-02-21 | |
| Crysdot LLC | CD12090238-5g |
Benzyl 4-(benzyloxy)-3-hydroxybenzoate |
263277-12-9 | 95+% | 5g |
$671 | 2024-07-24 |
Benzyl 4-(benzyloxy)-3-hydroxybenzoate Related Literature
-
Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
-
Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
-
Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707
-
Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
Additional information on Benzyl 4-(benzyloxy)-3-hydroxybenzoate
Recent Advances in the Study of Benzyl 4-(benzyloxy)-3-hydroxybenzoate (CAS: 263277-12-9) in Chemical Biology and Pharmaceutical Research
Benzyl 4-(benzyloxy)-3-hydroxybenzoate (CAS: 263277-12-9) is a synthetic compound that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its benzyl-protected phenolic hydroxyl group, has been explored for its diverse biological activities, including anti-inflammatory, antioxidant, and antimicrobial properties. Recent studies have further elucidated its molecular mechanisms and potential therapeutic uses, making it a promising candidate for drug development.
One of the key areas of research involving Benzyl 4-(benzyloxy)-3-hydroxybenzoate is its role as an intermediate in the synthesis of more complex bioactive molecules. For instance, it has been utilized in the preparation of polyphenolic derivatives, which are known for their potent antioxidant effects. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that derivatives of this compound exhibited significant radical scavenging activity, surpassing that of standard antioxidants like ascorbic acid. This finding underscores its potential in developing novel therapeutics for oxidative stress-related diseases.
In addition to its antioxidant properties, Benzyl 4-(benzyloxy)-3-hydroxybenzoate has been investigated for its anti-inflammatory effects. A recent preclinical study highlighted its ability to inhibit key inflammatory mediators such as cyclooxygenase-2 (COX-2) and nuclear factor-kappa B (NF-κB). These findings, published in Bioorganic & Medicinal Chemistry Letters, suggest that the compound could serve as a lead structure for designing new anti-inflammatory drugs with improved efficacy and reduced side effects compared to existing therapies.
Another promising avenue of research involves the antimicrobial potential of Benzyl 4-(benzyloxy)-3-hydroxybenzoate. A 2022 study in the European Journal of Medicinal Chemistry reported that this compound exhibited broad-spectrum activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. Mechanistic studies revealed that it disrupts bacterial cell membrane integrity and inhibits biofilm formation, making it a valuable candidate for addressing the global challenge of antibiotic resistance.
Despite these advancements, challenges remain in the clinical translation of Benzyl 4-(benzyloxy)-3-hydroxybenzoate. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further pharmacokinetic and pharmacodynamic studies. However, the compound's versatility and demonstrated bioactivities position it as a valuable tool in chemical biology and a promising scaffold for drug discovery. Future research should focus on optimizing its structure-activity relationships and exploring its potential in combination therapies.
263277-12-9 (Benzyl 4-(benzyloxy)-3-hydroxybenzoate) Related Products
- 2150-38-1(Methyl 3,4-dimethoxybenzoate)
- 1916-07-0(Methyl 3,4,5-trimethoxybenzoate)
- 6178-44-5(Ethyl 3,4,5-Trimethoxybenzoate)
- 10543-12-1(4-(Acetyloxy)-3-methoxybenzoic Acid)
- 1570-05-4(3,4-Bis(phenylmethoxy)-benzoic Acid)
- 3943-77-9(Ethyl 3,4-dimethoxybenzoate)
- 6702-50-7(Methyl isovanillate)
- 23676-09-7(Ethyl 4-ethoxybenzoate)
- 617-05-0(Ethyl vanillate)
- 3943-74-6(Methyl vanillate)